E-LIB Suche - Ergebnisse für: Marie José Kersten

1

Combining brentuximab vedotin with dexamethasone, high-dose..:

Marie José Kersten ; Julia Driessen ; Josée M. Zijlstra...
Haematologica. 106 (2020) 4 - p. 1129-1137 , 2020

Link: https://doi.org/10.3324/..

2

The dual HCK/BTK inhibitor KIN-8194 impairs growth and inte..:

Lantermans, Hildo C. ; Ma, Fangxue ; Kuil, Annemieke...
Leukemia. 38 (2024) 7 - p. 1570-1580 , 2024

Link: https://doi.org/10.1038/..

3

Brentuximab vedotin and chemotherapy in relapsed/refractory..:

Driessen, Julia ; de Wit, Fer ; Herrera, Alex F....
Blood Advances. 8 (2024) 11 - p. 2740-2752 , 2024

Link: https://doi.org/10.1182/..

4

Dropout from exercise trials among cancer survivors—An indi..:

Western, Benedikte ; Ivarsson, Andreas ; Vistad, Ingvild...
Scandinavian Journal of Medicine & Science in Sports. 34 (2024) 2 - p. , 2024

Link: https://doi.org/10.1111/..

5

Durable response after tisagenlecleucel in adults with rela..:

Dreyling, Martin ; Fowler, Nathan Hale ; Dickinson, Michael...
Blood. 143 (2024) 17 - p. 1713-1725 , 2024

Link: https://doi.org/10.1182/..

6

Treatment and outcomes for patients with relapsed or refrac..:

Pennings, Elise R. A. ; Durmaz, Müjde ; Visser, Otto...
Blood Cancer Journal. 14 (2024) 1 - p. , 2024

Link: https://doi.org/10.1038/..

7

Outcomes of subsequent antilymphoma therapies after second-..:

Ghobadi, Armin ; Munoz, Javier ; Westin, Jason R....
Blood Advances. 8 (2024) 11 - p. 2982-2990 , 2024

Link: https://doi.org/10.1182/..

8

HOVON 104, long‐term follow‐up of bortezomib‐dexamethasone ..:

Minnema, Monique C. ; Nasserinejad, Kazem ; Hegenbart, Ute...
eJHaem. , 2024

Link: https://doi.org/10.1002/..

9

A Robust Severe Acute Respiratory Syndrome Coronavirus 2 (S..:

Vergouwe, Magda ; Biemond, Jason J ; van der Straten, Karlijn...
The Journal of Infectious Diseases. , 2024

Link: https://doi.org/10.1093/..

10

Treatment strategies and outcome in relapsed peripheral T-c..:

Brink, Mirian ; Huisman, Francien ; Meeuwes, Frederik O....
Blood Advances. 8 (2024) 14 - p. 3619-3628 , 2024

Link: https://doi.org/10.1182/..

11

Axicabtagene ciloleucel vs standard of care in second-line ..:

Locke, Frederick L. ; Oluwole, Olalekan O. ; Kuruvilla, John...
Blood. 143 (2024) 24 - p. 2464-2473 , 2024

Link: https://doi.org/10.1182/..

12

Long-term outcomes of patients with large B-cell lymphoma t..:

Oluwole, Olalekan O. ; Forcade, Edouard ; Muñoz, Javier...
Bone Marrow Transplantation. 59 (2024) 3 - p. 366-372 , 2024

Link: https://doi.org/10.1038/..

13

Clinical Outcomes of Patients with Relapsed/Refractory Foll..:

Schuster, Stephen J. ; Fowler, Nathan H. ; Dickinson, Michael...
Transplantation and Cellular Therapy. 30 (2024) 2 - p. S38-S39 , 2024

Link: https://doi.org/10.1016/..

14

Safety and Efficacy of Axicabtagene Ciloleucel versus Stand..:

Westin, Jason R. ; Locke, Frederick L. ; Dickinson, Michael...
Clinical Cancer Research. 29 (2023) 10 - p. 1894-1905 , 2023

Link: https://doi.org/10.1158/..

15

Moderators of exercise effects on self-reported cognitive f..:

Hiensch, Anouk E. ; Beckhaus, Julia ; Witlox, Lenja...
Journal of Cancer Survivorship. , 2023

Link: https://doi.org/10.1007/..